The technological innovations in gastro-enterologic interventions make possible to perform more and more invasive procedures. The invasive gastro-enterology achieves in different stages of early gastric cancer the same long term oncologic results with lower risk and complication rate compared to surgical interventions. It means, that nowadays the treatment of early gastric cancer is on the borderline of invasive gastro-enterology and minimal invasive surgery. In our paper we were trying to find the answer for the question, in which stages of early gastric cancer should be chosen currently invasive gastro-enterological, surgical or hybrid intervention, applying the two methods at the same time.

The FTRD device, which provides endoscopic full-thickness resection, has been available since 2018 in Hungary. The indications include the removal of submucosal lesions, non-lifting adenomas and early carcinomas (also providing the accurate staging), however its role in the everyday practice is not yet fully determined due to the limited evidence of its practical application. Its use is restricted by licence, and applying for individual funding can compensate for the relatively high cost of the device.